Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tracon Pharma (NQ: TCON )

0.2175 -0.0016 (-0.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 269,115
Open 0.2200
Bid (Size) 0.2107 (1)
Ask (Size) 0.2225 (155)
Prev. Close 0.2191
Today's Range 0.2095 - 0.2205
52wk Range 0.1831 - 2.190
Shares Outstanding 24,059,460
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024 
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

YTD
-85.00%
-85.00%
1 Month
-11.94%
-11.94%
3 Month
-42.76%
-42.76%
6 Month
-87.05%
-87.05%
1 Year
-87.78%
-87.78%

More News

Read More
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
A Preview Of TRACON Pharma's Earnings
Via Benzinga
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
Earnings Scheduled For August 14, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
What's Going On With TRACON Pharmaceuticals Shares Today
Via Benzinga
TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
TRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
TRACON Pharmaceuticals Announces Poster Presentations for Envafolimab and TRC102 at the 2023 ASCO Annual Meeting
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.